These results were consistent with another study in which there were no difference in chemerin levels between asymptomatic type 2 diabetic patients with CAD and without CAD, suggesting that chemerin is not a biomarker of patients with stable CAD [36]. The gene discussed is RARRES2; the disease is coronary artery disorder.